Paroxysmal Kinesigenic Dyskinesia Caused by 16p11.2 Microdeletion

Tremor and Other Hyperkinetic Movements

Volumn 2014, Issue 1, 2014, Pages

  Termsarasab, Pichet ^a   Yang, Amy C ^a   Reiner, Jennifer ^a   Mei, Hui ^a   Scott, Stuart A ^a   Frucht, Steven J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

16p11.2 microdeletion; movement disorders; Paroxysmal kinesigenic dyskinesia

Indexed keywords

CARBAMAZEPINE;

ARTICLE; ASPERGER SYNDROME; BACKACHE; BACTERIAL ARTIFICIAL CHROMOSOME; CASE REPORT; CHILD; COMPARATIVE GENOMIC HYBRIDIZATION; DYSTONIA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE MUTATION; HUMAN; MALE; MICROARRAY ANALYSIS; MICRODELETION; PAROXYSMAL KINESIGENIC DYSKINESIA; SCHOOL CHILD; SEQUENCE ANALYSIS; SPONDYLOLISTHESIS;

EID: 84977885081     PISSN: None     EISSN: 21608288     Source Type: Journal    
DOI: 10.7916/D8N58K0Q     Document Type: Article

References (35)

1. Szepetowski P, Rochette J, Berquin P, Piussan C, Lathrop GM, Monaco AP. Familial infantile convulsions and paroxysmal choreoathetosis: A new neurological syndrome linked to the pericentromeric region of human chromosome 16. Am J Hum Genet 1997;61:889–898, doi: http://dx.doi.org/ 10.1086/514877.
2. Chen WJ, Lin Y, Xiong ZQ, et al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 2011;43:1252–1255, doi: http://dx.doi.org/10.1038/ng.1008.
3. Heron SE, Dibbens LM. Role of PRRT2 in common paroxysmal neurological disorders: A gene with remarkable pleiotropy. J Med Genet 2013;50: 133–139, doi: http://dx.doi.org/10.1136/jmedgenet-2012-101406.
4. Lipton J, Rivkin MJ. 16p11.2-related paroxysmal kinesigenic dyskinesia and dopa-responsive parkinsonism in a child. Neurology 2009;73:479–480, doi: http://dx.doi.org/10.1212/WNL.0b013e3181b16393.
5. Dale RC, Grattan-Smith P, Fung VS, Peters GB. Infantile convulsions and paroxysmal kinesigenic dyskinesia with 16p11.2 microdeletion. Neurology 201 1; 77: 1401–1402, doi: http://dx.doi.org/10.1212/WNL. 0b013e31823152d7.
6. Dale RC, Grattan-Smith P, Nicholson M, Peters GB. Microdeletions detected using chromosome microarray in children with suspected genetic movement disorders: A single-centre study. Dev Med Child Neurol 2012;54:618– 623, doi: http://dx.doi.Org/10.1111/j.1469-8749.2012.04287.x.
7. Weber A, Kohler A, Hahn A, Neubauer B, Muller U. Benign infantile convulsions (IC) and subsequent paroxysmal kinesigenic dyskinesia (PKD) in a patient with 16p11.2 microdeletion syndrome. Neurogenetics 2013;14:251–253. doi: http://dx.doi.org/10.1007/s10048-013-0376-7.
8. Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and micro duplication at 16p11.2 and autism. N Engl J Med 2008;358:667–675, doi: http://dx.doi.org/10.1056/NEJMoa075974.
9. Fernandez BA, Roberts W, Chung B, et al. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J Med Genet 2010;47:195–203, doi: http://dx.doi.org/10.1136/jmg.2009.069369.
10. Shinawi M, Liu P, Kang SH, et al. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 2010: 47:332–341, doi: http://dx.doi.org/10.1136/jmg.2009.073015.
11. Bijlsma EK, Gijsbers AC, Schuurs-Hoeijmakers JH, et al. Extending the phenotype of recurrent rearrangements of 16p11.2: Deletions in mentally retarded patients without autism and in normal individuals. Eur J Med Genet 2009;52:77–87, doi: http://dx.doi.Org/10.1016/j.ejmg.2009.03.006.
12. Glessner JT, Wang K, Cai G, et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009;459:569–573, doi: http://dx.doi.org/10.1038/nature07953.
13. Hanson E, Nasir RH, Fong A, et al. Cognitive and behavioral characterization of 16p11.2 deletion syndrome. J Dev Behav Pediatr 2010;31: 649–657, doi: http://dx.doi.org/10.1097/DBP.0b013e3181ea50ed.
14. Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011;43:838–846, doi: http:// dx.doi.org/10.1038/ng.909.
15. Hanson E, Bernier R, Porche K, et al. The cognitive and behavioral phenotype of the 16p11.2 deletion in a clinically ascertained population. Biol Psychiatry2014.
16. Zufferey F, Sherr EH, Beckmann ND, et al. A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders. J Med Genet 2012;49:660–668, doi: http://dx.doi.org/10-1136/jmedgenet-2012-101203.
17. Lee YC, Lee MJ, Yu HY, et al. PRRT2 mutations in paroxysmal kinesigenic dyskinesia with infantile convulsions in a Taiwanese cohort. PLoS One 2012;7:e38543, doi: http://dx.doi.org/10.1371/journal.pone.0038543.
18. Meneret A, Grabli D, Depienne C, et al. PRRT2 mutations: A major cause of paroxysmal kinesigenic dyskinesia in the European population. Neurology 2012;79:170–174, doi: http://dx.doi.org/10.1212/WNL. 0b013e31825f06c3.
19. Groffen AJ, Klapwijk T, van Rootselaar AF, Groen JL, Tijssen MA. Genetic and phenotypic heterogeneity in sporadic and familial forms of paroxysmal dyskinesia. J Neurol 2013;260:93–99, doi: http://dx.doi.org/10. 1007A00415-012-6592-5.
20. Chen YP, Song W, Yang J, et al. PRRT2 mutation screening in patients with paroxysmal kinesigenic dyskinesia from southwest China. Eur J Neurol 2014;21:174–176, doi: http://dx.doi.org/10.1111/ene.12122.
21. Erro R, Sheerin UM, Bhatia KP. Paroxysmal dyskinesias revisited: a review of 500 genetically proven cases and a new classification. Mov Disord2014: 29:1108–1116.
22. WangJL, Cao L, Li XH, et al. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain 2011;134:3493–3501, doi: http://dx.doi.org/10.1093/brain/awr289.
23. Heron SE, Grinton BE, Kivity S, et al. PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am J Hum Genet 2012;90:152–160, doi: http://dx.doi.org/10. 1016/j.ajhg.2011.12.003.
24. RosenfeldJA, Coppinger J, Bejjani BA, et al. Speech delays and behavioral problems are the predominant features in individuals with developmental delays and 16p11.2 microdeletions and microduplications. J Neurodev Disord 2010;2:26–38, doi: http://dx.doi.org/10.1007/s11689-009-9037-4.
25. McCarthy SE, Makarov V, Kirov G, et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 2009;41:1223–1227, doi: http://dx. doi.org/10.1038/ng.474.
26. Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008;82:477–488. doi: http://dx.doi.Org/10.1016/j.ajhg.2007.12.009.
27. Bachmann-Gagescu R, Mefford HC, Cowan C, et al. Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity. Genet Med 2010;12:641–647, doi: http://dx. doi.org/10.1097/GIM.0b013e3181ef4286.
28. Guha S, Rees E, Darvasi A, et al. Implication of a rare deletion at distal 16p11.2 in schizophrenia. JAMA Psychiatry 2013;70:253–260, doi: http://dx. doi.org/10.1001/2013.jamapsychiatry.71.
29. Walters RG, Jacquemont S, Valsesia A, et al. A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature 2010;463:671–675, doi: http://dx.doi.org/10.1038/nature08727.
30. Sparrow DB, McInerney-Leo A, Gucev ZS, et al. Autosomal dominant spondylocostal dysostosis is caused by mutation in TBX6. Hum Mol Genet 2013: 22:1625–1631, doi: http://dx.doi.org/10.1093/hmg/ddt012.
31. Boyden ED, Campos-Xavier AB, Kalamajski S, et al. Recurrent dominant mutations affecting two adjacent residues in the motor domain of the monomeric kinesin KIF22 result in skeletal dysplasia and joint laxity. Am J Hum Genet 2011;89: 767–772, doi: http://dx.doi.Org/10.1016/j.ajhg.2011.10.016.
32. Min BJ, Kim N, Chung T, et al. Whole-exome sequencing identifies mutations of KIF22 in spondyloepimetaphyseal dysplasia with joint laxity, leptodactylic type. Am J Hum Genet 2011;89:760–766, doi: http://dx.doi.org/10. 1016/j.ajhg.2011.10.015.
33. Kreuder J, Borkhardt A, Repp R, et al. Brief report: Inherited metabolic myopathy and hemolysis due to a mutation in aldolase A. N Engl J Med1996: 334:1100–1104.
34. MacDonald JR, Ziman R, Yuen RK, Feuk L, Scherer SW. The Database of Genomic Variants: A curated collection of structural variation in the human genome. Nucleic Acids Res 2014;42:D986–992, doi: http://dx.doi. org/10.1093/nar/gkt958.
35. Shaffer LG, American College of Medical Genetics Professional P. Guidelines C. American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation. Genet Med 2005;7:650–654, doi: http://dx.doi.org/10.1097/01. gim.0000186545.83160.1e.